{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:58:20Z","timestamp":1794657500296,"version":"4.9.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Government of India Department of Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cytogfr.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:17:39Z","timestamp":1755875859000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["From senescence to scarring: Exploring TGF-\u03b2 signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis"],"prefix":"10.1016","volume":"86","author":[{"given":"Shivani","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8825-3034","authenticated-orcid":false,"given":"Sapana","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2025.08.003_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu Rev. Physiol."},{"issue":"22","key":"10.1016\/j.cytogfr.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","article-title":"The essence of senescence","volume":"24","author":"Kuilman","year":"2010","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/0300985820943841","article-title":"Cellular senescence: mechanisms, morphology, and mouse models","volume":"57","author":"Beck","year":"2020","journal-title":"Vet. Pathol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","article-title":"A complex secretory program orchestrated by the inflammasome controls paracrine senescence","volume":"15","author":"Acosta","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/febs.16381","article-title":"The role of cellular senescence and SASP in tumour microenvironment","volume":"290","author":"Takasugi","year":"2023","journal-title":"FEBS J."},{"issue":"23-24","key":"10.1016\/j.cytogfr.2025.08.003_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.201009094","article-title":"Four faces of cellular senescence","volume":"192","author":"Rodier","year":"2011","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.08.003_bib8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/febs.16381","article-title":"The role of cellular senescence and SASP in tumour microenvironment","volume":"290","author":"Takasugi","year":"2023","journal-title":"Febs J."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib10","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9807","key":"10.1016\/j.cytogfr.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"19","key":"10.1016\/j.cytogfr.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/path.5680","article-title":"TGF-\u03b2 as a driver of fibrosis: physiological roles and therapeutic opportunities","volume":"254","author":"Budi","year":"2021","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-023-02751-8","article-title":"TGF-\u03b21 signalling in alzheimer's pathology and cytoskeletal reorganization: a specialized tau perspective","volume":"20","author":"Kapoor","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"34","key":"10.1016\/j.cytogfr.2025.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215095120","article-title":"A TGF-\u03b2\/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer","volume":"120","author":"Dasgupta","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/abbs\/gmx124","article-title":"The role of TGF-\u03b2 superfamily signaling in neurological disorders","volume":"50","author":"Kashima","year":"2018","journal-title":"Acta Biochim Biophys. Sin."},{"issue":"20","key":"10.1016\/j.cytogfr.2025.08.003_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205002","article-title":"TGF-\u03b2 signaling in cellular senescence and Aging-Related pathology","volume":"20","author":"Tominaga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.08.003_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.18632\/aging.100807","article-title":"Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients","volume":"7","author":"Yanai","year":"2015","journal-title":"Aging"},{"issue":"7501","key":"10.1016\/j.cytogfr.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","author":"van Deursen","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.201708092","article-title":"Senescence and aging: causes, consequences, and therapeutic avenues","volume":"217","author":"McHugh","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.08.003_bib28","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.18632\/aging.204743","article-title":"Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16\/RB-E2F-DREAM complex","volume":"15","author":"Kandhaya-Pillai","year":"2023","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat. Genet"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1164\/rccm.201408-1452OC","article-title":"Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis","volume":"190","author":"Yang","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib32","doi-asserted-by":"crossref","first-page":"L56","DOI":"10.1152\/ajplung.00213.2012","article-title":"Insufficient autophagy in idiopathic pulmonary fibrosis","volume":"304","author":"Araya","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","article-title":"The senescence-associated secretory phenotype and its regulation","volume":"117","author":"Lopes-Paciencia","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","article-title":"The senescence-associated secretory phenotype and its regulation","volume":"117","author":"Lopes-Paciencia","year":"2019","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cellsig.2011.12.006","article-title":"Emerging role of NF-\u03baB signaling in the induction of senescence-associated secretory phenotype (SASP)","volume":"24","author":"Salminen","year":"2012","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.08.003_bib37","article-title":"Roles of extracellular vesicles in the aging microenvironment and age-related diseases","volume":"10","author":"Yin","year":"2021","journal-title":"J. Extra Vesicles"},{"issue":"24","key":"10.1016\/j.cytogfr.2025.08.003_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130056","article-title":"Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis","volume":"4","author":"Wiley","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.08.003_bib39","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00037.2018","article-title":"Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis","volume":"315","author":"Waters","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","article-title":"Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis","volume":"203","author":"Yao","year":"2021","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.3390\/ijms22137012","article-title":"Cellular senescence in lung fibrosis","volume":"22","author":"Hernandez-Gonzalez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12931-023-02403-8","article-title":"Biomarkers of cellular senescence in idiopathic pulmonary fibrosis","volume":"24","author":"Aversa","year":"2023","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 regulation of TGF-\u03b21-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87732","article-title":"Elimination of p19ARF-expressing cells enhances pulmonary function in mice","volume":"1","author":"Hashimoto","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"19","key":"10.1016\/j.cytogfr.2025.08.003_bib48","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7351","key":"10.1016\/j.cytogfr.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.08.003_bib51","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical wnt signalling is required for TGF-\u03b2-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s12276-019-0371-7","article-title":"TGF-\u03b21\/IL-11\/MEK\/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency","volume":"52","author":"Chen","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg","year":"2009","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.08.003_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113611","article-title":"The role of TGF-\u03b2 signaling in lung cancer associated with idiopathic pulmonary fibrosis","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.08.003_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101118","article-title":"The E-Cadherin and N-Cadherin switch in Epithelial-to-Mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.08.003_bib58","doi-asserted-by":"crossref","first-page":"L83","DOI":"10.1152\/ajplung.00258.2012","article-title":"TGF-\u03b2-Smad3 signaling in emphysema and pulmonary fibrosis: an epigenetic aberration of normal development?","volume":"304","author":"Warburton","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","article-title":"Methylation determines fibroblast activation and fibrogenesis in the kidney","volume":"16","author":"Bechtel","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/abbs\/gmx122","article-title":"Crosstalk between TGF-\u03b2 signaling and epigenome","volume":"50","author":"Bai","year":"2018","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13069-015-0035-8","article-title":"Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis","volume":"8","author":"Neary","year":"2015","journal-title":"Fibrogenes. Tissue Repair"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.08.003_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071901","article-title":"MicroRNA control of TGF-\u03b2 signaling","volume":"19","author":"Suzuki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib63","first-page":"61","article-title":"Reactive oxygen species as signaling molecules in the development of lung fibrosis","volume":"190","author":"Gonzalez-Gonzalez","year":"2017","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.redox.2014.01.012","article-title":"NADPH oxidase-dependent redox signaling in TGF-\u03b2-mediated fibrotic responses","volume":"2","author":"Jiang","year":"2014","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.08.003_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-\u03b2-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.08.003_bib66","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib67","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1038\/s41467-023-40617-y","article-title":"Autocrine TGF-\u03b2-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis","volume":"14","author":"Enomoto","year":"2023","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.cytogfr.2025.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130056","article-title":"Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis","volume":"4","author":"Wiley","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41420-020-00316-9","article-title":"Mitochondrial dysfunction in fibrotic diseases","volume":"6","author":"Li","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib70","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104481","article-title":"Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability","volume":"90","author":"Nambiar","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib72","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.201810-1975TR","article-title":"Cellular senescence as a mechanism and target in chronic lung diseases","volume":"200","author":"Barnes","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12931-023-02403-8","article-title":"Biomarkers of cellular senescence in idiopathic pulmonary fibrosis","volume":"24","author":"Aversa","year":"2023","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2213-2600(20)30364-7","article-title":"Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study","volume":"9","author":"Duckworth","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib75","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1038\/s41467-022-32771-6","article-title":"Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development","volume":"13","author":"Pi\u00f1eiro-Hermida","year":"2022","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.cytogfr.2025.08.003_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153058","article-title":"Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis","volume":"7","author":"Radwanska","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12931-021-01801-0","article-title":"Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis","volume":"22","author":"Jessen","year":"2021","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib78","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00141013","article-title":"Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression","volume":"43","author":"Chien","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41598-017-00270-0","article-title":"Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis","volume":"7","author":"Aumiller","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib80","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The multiple functions and mechanisms of osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.18433\/jpps32306","article-title":"Periostin: a potential biomarker and therapeutic target in pulmonary diseases","volume":"25","author":"Alzobaidi","year":"2022","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib83","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1186\/s12967-024-05698-3","article-title":"SULF1 expression is increased and promotes fibrosis through the TGF-\u03b21\/SMAD pathway in idiopathic pulmonary fibrosis","volume":"22","author":"Tu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"38","key":"10.1016\/j.cytogfr.2025.08.003_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0987","article-title":"PKM2 promotes pulmonary fibrosis by stabilizing TGF-\u03b21 receptor I and enhancing TGF-\u03b21 signaling","volume":"8","author":"Gao","year":"2022","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"issue":"20","key":"10.1016\/j.cytogfr.2025.08.003_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90558","article-title":"Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis","volume":"1","author":"Xu","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib87","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1165\/rcmb.2020-0546OC","article-title":"Molecular signatures of idiopathic pulmonary fibrosis","volume":"65","author":"Konigsberg","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"205","key":"10.1016\/j.cytogfr.2025.08.003_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005964","article-title":"Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis","volume":"5","author":"Herazo-Maya","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib89","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1165\/rcmb.2020-0504OC","article-title":"Connective-Tissue growth factor contributes to TGF-\u03b21-induced lung fibrosis","volume":"66","author":"Yanagihara","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.08.003_bib90","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","article-title":"miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis","volume":"207","author":"Liu","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2014.12.007","article-title":"Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition","volume":"566","author":"Xiao","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib92","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ymthe.2016.12.017","article-title":"miR-18a-5p inhibits Sub-pleural pulmonary fibrosis by targeting TGF-\u03b2 receptor II","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib93","article-title":"Investigating the incidence of pulmonary abnormalities as identified by parametric response mapping in patients with lung cancer before radiation treatment","volume":"7","author":"Owen","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","article-title":"Emerging therapeutic opportunities for integrin inhibitors","volume":"21","author":"Slack","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib95","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5479","article-title":"Advancements in omics technologies: molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review)","volume":"55","author":"Zheng","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40610-021-00145-4","article-title":"Cellular senescence in idiopathic pulmonary fibrosis","volume":"7","author":"Kellogg","year":"2021","journal-title":"Curr. Mol. Biol. Rep."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcdb.2019.12.008","article-title":"Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis","volume":"101","author":"Merkt","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.08.003_bib98","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib99","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging","volume":"169","author":"Baar","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.08.003_bib100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/1873-3468.13057","article-title":"Regulation of cellular senescence via the FOXO 4-p53 axis","volume":"592","author":"Bourgeois","year":"2018","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.08.003_bib101","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.15252\/embr.201439245","article-title":"Senescence and apoptosis: dueling or complementary cell fates?","volume":"15","author":"Childs","year":"2014","journal-title":"EMBO Rep."},{"issue":"46","key":"10.1016\/j.cytogfr.2025.08.003_bib102","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib103","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1038\/s41467-019-12888-x","article-title":"Identification and characterization of cardiac glycosides as senolytic compounds","volume":"10","author":"Triana-Mart\u00ednez","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2016","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib105","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.18632\/aging.205581","article-title":"Exploring the effects of dasatinib, quercetin, and fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions","volume":"16","author":"Lee","year":"2024","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib106","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/acel.12587","article-title":"Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism","volume":"16","author":"Wang","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.cytogfr.2025.08.003_bib107","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"issue":"22","key":"10.1016\/j.cytogfr.2025.08.003_bib108","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.cytogfr.2025.08.003_bib109","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.08.003_bib110","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbadis.2012.10.005","article-title":"Integrin-mediated regulation of TGF\u03b2 in fibrosis","volume":"1832","author":"Henderson","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA)Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.08.003_bib112","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12249-024-02793-y","article-title":"Revolutionizing the treatment of idiopathic pulmonary fibrosis: from conventional therapies to advanced drug delivery systems","volume":"25","author":"Singh","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.08.003_bib113","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.chest.2020.08.2043","article-title":"Clinical molecular imaging of pulmonary CXCR4 expression to predict outcome of pirfenidone treatment in idiopathic pulmonary fibrosis","volume":"159","author":"Derlin","year":"2021","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.08.003_bib114","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2025.08.003_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117908","article-title":"Targeting the PI3K\/mTOR pathway in idiopathic pulmonary fibrosis: advances and therapeutic potential","volume":"115","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.08.003_bib116","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1172\/JCI90832","article-title":"Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis","volume":"127","author":"Xia","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.08.003_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081123","article-title":"Alvespimycin exhibits potential Anti-TGF-\u03b2 signaling in the setting of a proteasome activator in rats with Bleomycin-Induced pulmonary fibrosis: a promising novel approach","volume":"16","author":"Mohammed","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"460","key":"10.1016\/j.cytogfr.2025.08.003_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ t cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.08.003_bib119","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12890-024-03260-x","article-title":"IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN\/AKT\/ERK pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pulm. Med."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:22:29Z","timestamp":1781234549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":119,"alternative-id":["S1359610125001030"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.08.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From senescence to scarring: Exploring TGF-\u03b2 signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}